Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Ceribelli

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
Seminars in Arthritis and Rheumatism|April 25, 2018
Comment on: Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvementAngela Ceribelli, Natasa Isailovic, Maria De Santis, et al.
Journal of Autoimmunity|April 23, 2017
Lessons learned from twins in autoimmune and chronic inflammatory diseasesElena Generali, Angela Ceribelli, Maria Antonietta Stazi, et al.
Auto- Immunity Highlights|May 23, 2015
The Th17 axis in psoriatic disease: pathogenetic and therapeutic implicationsBeatrice Marinoni, Angela Ceribelli, Marco S Massarotti, et al.
Clinics in Dermatology|September 1, 2015
Seronegative reactive spondyloarthritis and the skinElena Generali, Angela Ceribelli, Marco Massarotti, et al.
Annals of the New York Academy of Sciences|September 6, 2007
Anti-cardiolipin and anti-beta2-glycoprotein I antibodies: performance of new commercial ELISA kitsLaura Andreoli, Fabio Malacarne, Angela Ceribelli, et al.
Frontiers in Medicine|April 3, 2023
Interstitial lung disease associated with inflammatory myositis: Autoantibodies, clinical phenotypes, and progressive fibrosisAngela Ceribelli, Antonio Tonutti, Natasa Isailovic, et al.
Seminars in Arthritis and Rheumatism|January 11, 2025
Established and novel insights to guide cancer assessment in patients with idiopathic inflammatory myopathiesAngela Ceribelli, Antonio Tonutti, Natasa Isailovic, et al.
Autoimmunity Reviews|April 9, 2019
Systemic rheumatic diseases: From biological agents to small moleculesPiercarlo Sarzi-Puttini, Angela Ceribelli, Daniela Marotto, et al.
FEBS Letters|May 24, 2011
MicroRNAs in rheumatoid arthritisAngela Ceribelli, Md A Nahid, Minoru Satoh, et al.
Expert Opinion on Drug Safety|December 19, 2014
Safety issues and concerns of new immunomodulators in rheumatologyCarlo Selmi, Angela Ceribelli, Stanley M Naguwa, et al.
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
Seminars in Arthritis and Rheumatism|April 25, 2018
Comment on: Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvementAngela Ceribelli, Natasa Isailovic, Maria De Santis, et al.
Journal of Autoimmunity|April 23, 2017
Lessons learned from twins in autoimmune and chronic inflammatory diseasesElena Generali, Angela Ceribelli, Maria Antonietta Stazi, et al.
Auto- Immunity Highlights|May 23, 2015
The Th17 axis in psoriatic disease: pathogenetic and therapeutic implicationsBeatrice Marinoni, Angela Ceribelli, Marco S Massarotti, et al.
Clinics in Dermatology|September 1, 2015
Seronegative reactive spondyloarthritis and the skinElena Generali, Angela Ceribelli, Marco Massarotti, et al.
Annals of the New York Academy of Sciences|September 6, 2007
Anti-cardiolipin and anti-beta2-glycoprotein I antibodies: performance of new commercial ELISA kitsLaura Andreoli, Fabio Malacarne, Angela Ceribelli, et al.
Frontiers in Medicine|April 3, 2023
Interstitial lung disease associated with inflammatory myositis: Autoantibodies, clinical phenotypes, and progressive fibrosisAngela Ceribelli, Antonio Tonutti, Natasa Isailovic, et al.
Seminars in Arthritis and Rheumatism|January 11, 2025
Established and novel insights to guide cancer assessment in patients with idiopathic inflammatory myopathiesAngela Ceribelli, Antonio Tonutti, Natasa Isailovic, et al.
Autoimmunity Reviews|April 9, 2019
Systemic rheumatic diseases: From biological agents to small moleculesPiercarlo Sarzi-Puttini, Angela Ceribelli, Daniela Marotto, et al.
FEBS Letters|May 24, 2011
MicroRNAs in rheumatoid arthritisAngela Ceribelli, Md A Nahid, Minoru Satoh, et al.
Expert Opinion on Drug Safety|December 19, 2014
Safety issues and concerns of new immunomodulators in rheumatologyCarlo Selmi, Angela Ceribelli, Stanley M Naguwa, et al.
Pageof 11